Keywords: pfizer, lyrica, cuts, seizure, rate, half, shares
Pfizer's Lyrica cuts seizure rate in half
Article | 21 February 2005
Shares in Pfizer, the world's largest pharmaceutical firm, rose 1.3% to $25.48 on February 14 following positive news related to its anti-epileptic drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
